Sandor Spisak

9PUBLICATIONS
78CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 23, 2023
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.

Sandor Spisak, Viktoria Tisza, Pier Vitale Nuzzo

|Jan 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.

Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca

|Aug 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.

Agostina Nardone, Xintao Qiu, Sandor Spisak

|Apr 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.

Xiaodong Lu, Ka-Wing Fong, Galina Gritsina

|Dec 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.

Haiyang Guo, Yiming Wu, Mannan Nouri

|Dec 15, 2021
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.

Jacob E Berchuck, Sylvan C Baca, Heather M McClure

Pageof 2

Frequent Collaborators

4 joint publications

Matthew L Freedman

4 joint publications

Istvan Csabai

3 joint publications

Kate Lawrenson

3 joint publications

Alexander Gusev